Home LiteratureArticle Details
PMID: 12169632 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

The EMBO journal ·Vol. 21 ·No. 16 ·2002-08-15 ·Pages 4297-306

Schulte CE, von Lindern M, Steinlein P, Beug H, Wiedemann LM

Abstract

The MLL gene is targeted by chromosomal translocations, which give rise to heterologous MLL fusion proteins and are associated with distinct types of acute lymphoid and myeloid leukaemia. To determine how MLL fusion proteins alter the proliferation and/or differentiation of primary haematopoietic progenitors, we introduced the MLL-AF9 and MLL-ENL fusion proteins into primary chicken bone marrow cells. Both fusion proteins caused the sustained outgrowth of immature haematopoietic cells, which was strictly dependent on stem cell factor (SCF). The renewing cells have a long in vitro lifespan exceeding the Hayflick limit of avian cells. Analysis of clonal cultures identified the renewing cells as immature, multipotent progenitors, expressing erythroid, myeloid, lymphoid and stem cell surface markers. Employing a two-step commitment/differentiation protocol involving the controlled withdrawal of SCF, the MLL-ENL-transformed progenitors could be induced to terminal erythroid or myeloid differentiation. Finally, in cooperation with the weakly leukaemogenic receptor tyrosine kinase v-Sea, the MLL-ENL fusion protein gave rise to multilineage leukaemia in chicks, suggesting that other activated, receptor tyrosine kinases can substitute for ligand-activated c-Kit in vivo.

MeSH Terms
Animals Antigens, Differentiation/biosynthesis B-Lymphocytes/cytology Bone Marrow Cells Cell Line Cell Lineage Cell Transformation, Neoplastic Chick Embryo Cloning, Molecular Erythroid Precursor Cells/cytology Hematopoietic Stem Cells/cytology Myeloid Cells/cytology Myeloid-Lymphoid Leukemia Protein Nuclear Proteins/physiology Oncogene Proteins, Fusion/physiology Oncogene Proteins, Viral/physiology Recombinant Fusion Proteins Stem Cell Factor/physiology
Chemicals
Antigens, Differentiation MLL-ENL oncoprotein, human Nuclear Proteins Oncogene Proteins, Fusion Oncogene Proteins, Viral Recombinant Fusion Proteins Stem Cell Factor env-sea oncogene protein, Avian Erythroblastosis Retrovirus Myeloid-Lymphoid Leukemia Protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Schulte Cathleen E
Leukaemia Research Fund Centre, Institute of Cancer Research, London, UK. schulte@nt.imp.univie.ac.at
von Lindern Marieke
Steinlein Peter
Beug Hartmut
Wiedemann Leanne M
References (53)
53 references, click to expand
  1. The glucocorticoid receptor is required for stress erythropoiesis.
    Genes Dev. 1999 Nov 15;13(22):2996-3002 PMID: 10580006
  2. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.
    Br J Haematol. 1999 Dec;107(3):674-6 PMID: 10583275
  3. C-kit mutations in core binding factor leukemias.
    Blood. 2000 Jan 15;95(2):726-7 PMID: 10660321
  4. Effects of mutant c-kit in early myeloid cells.
    Leuk Lymphoma. 2000 Mar;37(1-2):233-43 PMID: 10721793
  5. c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.
    Br J Haematol. 1999 Jun;105(4):894-900 PMID: 10554798
  6. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Leukemia. 2000 Jul;14(7):1232-8 PMID: 10914547
  7. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
    J Pharmacol Exp Ther. 2000 Oct;295(1):139-45 PMID: 10991971
  8. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.
    Blood. 2001 Apr 15;97(8):2434-9 PMID: 11290608
  9. STI571: targeting BCR-ABL as therapy for CML.
    Oncologist. 2001;6(3):233-8 PMID: 11423669
  10. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
    Mol Cell Biol. 2001 Sep;21(17):5857-68 PMID: 11486025
  11. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Cancer Res. 2001 Sep 1;61(17):6480-6 PMID: 11522644
  12. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
    Oncogene. 2001 Sep 10;20(40):5695-707 PMID: 11607819
  13. Changes in the expression of membrane antigens during the differentiation of chicken erythroblasts.
    J Cell Biochem. 1982;18(3):351-62 PMID: 7040433
  14. Identification of a T3/T cell receptor complex in chickens.
    J Exp Med. 1986 Jul 1;164(1):375-80 PMID: 2425031
  15. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo.
    J Biol Chem. 1986 Oct 15;261(29):13517-25 PMID: 3759975
  16. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.
    J Virol. 1987 Oct;61(10):3004-12 PMID: 3041020
  17. Abnormal glycosylation of the env-sea oncogene product inhibits its proteolytic cleavage and blocks its transforming ability.
    Oncogene. 1988 Apr;2(4):317-26 PMID: 2834683
  18. An avian B-lymphocyte protein associated with beta 2-microglobulin.
    Immunogenetics. 1990;32(1):1-7 PMID: 2197221
  19. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.
    Blood. 1991 Feb 1;77(3):440-7 PMID: 1991161
  20. The dynamics of compartmentalization of embryonic muscle by extracellular matrix molecules.
    Dev Biol. 1991 Sep;147(1):46-61 PMID: 1879615
  21. Expression of immunoglobulin genes in the avian embryo bone marrow revealed by retroviral transformation.
    Eur J Immunol. 1991 Oct;21(10):2529-36 PMID: 1655468
  22. Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent.
    Cell. 1992 Jul 24;70(2):201-13 PMID: 1322247
  23. The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation.
    Oncogene. 1992 Oct;7(10):1903-11 PMID: 1408132
  24. A novel putative receptor protein tyrosine kinase of the met family.
    Oncogene. 1993 May;8(5):1195-202 PMID: 8386824
  25. Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors.
    Cell. 1993 Jul 16;74(1):157-69 PMID: 7687522
  26. Transformation of chicken bone marrow cells by the v-ski oncogene.
    Oncogene. 1993 Dec;8(12):3221-8 PMID: 7504231
  27. Retroviral capture of c-erbB proto-oncogene sequences: rapid evolution of distinct viral genomes carrying mutant v-erbB genes with different transforming capacities.
    Oncogene. 1994 May;9(5):1307-20 PMID: 8152791
  28. Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro.
    Growth Factors. 1994;10(1):1-16 PMID: 8179929
  29. In vitro growth of factor-dependent multipotential hematopoietic cells is induced by the nuclear oncoprotein v-Ski.
    Oncogene. 1995 Jul 6;11(1):59-72 PMID: 7624132
  30. Avian hematopoietic cell culture: in vitro model systems to study oncogenic transformation of hematopoietic cells.
    Methods Enzymol. 1995;254:41-76 PMID: 8531702
  31. Altered Hox expression and segmental identity in Mll-mutant mice.
    Nature. 1995 Nov 30;378(6556):505-8 PMID: 7477409
  32. Self renewal and differentiation in primary avian hematopoietic cells: an alternative to mammalian in vitro models?
    Curr Top Microbiol Immunol. 1996;211:29-39 PMID: 8585961
  33. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
    Blood. 1996 Feb 1;87(3):1123-33 PMID: 8562938
  34. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.
    Blood. 1996 Feb 1;87(3):1134-9 PMID: 8562939
  35. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.
    Cell. 1996 Jun 14;85(6):853-61 PMID: 8681380
  36. Cytogenetic findings in acute biphenotypic leukaemia.
    Leukemia. 1996 Aug;10(8):1283-7 PMID: 8709632
  37. HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors.
    J Cell Biol. 1996 Dec;135(6 Pt 1):1655-68 PMID: 8978830
  38. Identification of chicken Bu-1 alloantigens using the monoclonal antibody AV20.
    Vet Immunol Immunopathol. 1996 Dec;55(1-3):225-34 PMID: 9014319
  39. Aetiology of acute leukaemia.
    Lancet. 1997 Feb 1;349(9048):344-9 PMID: 9024390
  40. Multilineage gene expression precedes commitment in the hemopoietic system.
    Genes Dev. 1997 Mar 15;11(6):774-85 PMID: 9087431
  41. Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein.
    Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7286-91 PMID: 9207083
  42. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
    EMBO J. 1997 Jul 16;16(14):4226-37 PMID: 9250666
  43. Avian Ikaros gene is expressed early in embryogenesis.
    Eur J Immunol. 1997 Aug;27(8):1853-7 PMID: 9295018
  44. Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors.
    J Cell Biol. 1997 Sep 22;138(6):1395-407 PMID: 9298993
  45. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    EMBO J. 1997 Sep 15;16(18):5639-53 PMID: 9312023
  46. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
    Mol Cell Biol. 1998 Jan;18(1):122-9 PMID: 9418860
  47. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants.
    Leukemia. 1998 May;12(5):805-10 PMID: 9593285
  48. Isolation and characterization of a pufferfish MLL (mixed lineage leukemia)-like gene (fMll) reveals evolutionary conservation in vertebrate genes related to Drosophila trithorax.
    Oncogene. 1998 Jun 25;16(25):3233-41 PMID: 9681821
  49. Glycoprotein IIb-IIIa is expressed on avian multilineage hematopoietic progenitor cells.
    Blood. 1999 May 1;93(9):2898-906 PMID: 10216084
  50. Control of lymphocyte development by the Ikaros gene family.
    Curr Opin Immunol. 1999 Apr;11(2):167-71 PMID: 10322160
  51. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis.
    EMBO J. 1999 Jul 1;18(13):3564-74 PMID: 10393173
  52. The c-kit receptor and its ligand stem cell factor in childhood malignant lymphoid precursors.
    J Interferon Cytokine Res. 1999 Sep;19(9):981-7 PMID: 10505738
  53. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Nat Genet. 2002 Jan;30(1):41-7 PMID: 11731795
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2002-08-15
Pages
4297-306
Language
English
Region
England
NLM ID
8208664
PMCID
PMC125405
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com